Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$17.01 USD
+1.26 (8.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $16.97 -0.04 (-0.24%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Mesoblast Limited has a market cap of $2.02B, which represents its share price of $15.75 multiplied by its outstanding shares number of 128.00M. As a mid-cap company, MESO's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MESO 17.01 +1.26(8.00%)
Will MESO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MESO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MESO
Mesoblast Limited (MESO) Is Up 40.59% in One Week: What You Should Know
Mesoblast Limited (MESO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
MESO: What are Zacks experts saying now?
Zacks Private Portfolio Services
MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug
What Awaits These 4 Biotech Stocks That More Than Doubled in 2024
MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease
Other News for MESO
Is MESO primed for upward momentum? Pocket Pivot shows up after rising 4.51%
MESO falls 3.4% on September 17, leaving the technical picture intact
MESO forms Narrow Range Bar on September 16
Is MESO set to rally? Crossed Above 20 Day Moving Average shows up after advancing 4.32%
MESO Fell Below 20 Day Moving Average on September 12